January 8 - 9, 2013 (San Francisco, CA)
New Paradigms to Fund Life Science Innovation
For a third successful year, GRS’ Executive Chair, Dr. Sandra Garrett, and Dr. Peter Milner (CEO / co-founder of Heart Metabolics, CV Therapeutics, ARYx Therapeutics and Optivia Biotechnology) co-chaired a key life science funding conference, New Paradigms in San Francisco, California. This conference has consistently attracted an outstanding speaking faculty of some of the most influential leaders from the biotech, pharmaceutical and life science investment communities and provides an exceptional format focused on finding alternative sources to fund and manage drug development. For conference details, visit the conference website.

 

April 27, 2012
GRS announces agreement with Mediciti for the development of clinical research initiatives in India. GRS has formalized plans with a leading Indian healthcare institution for expansion of clinical research innovations in Asia including the development of a top-performance clinical coordinating center, a focused clinical research training program and the development of India’s first electronic medical records (EMR) initiative for the promotion of innovation in global therapeutic development. News Announcement.

January 10-12, 2012
For the second year in row, GRS’ Dr. Sandra Garrett successfully co-chaired the industry conference New Paradigms to Fund and Move Drug Development, in San Francisco, following the JP Morgan Healthcare Conference. The New Paradigms conference is the only event addressing alternative sources to fund product development together with effective regulatory, study design and outsourcing strategies for successful and efficient therapeutic product development.

May 5, 2011
GRS Selects MedStar Health Research Institute (MHRI) as Comprehensive Cardiac Imaging Corelab.
Press Release

January 13-14, 2011
GRS’ Dr. Sandra Garrett successfully co-chaired the industry conference New Paradigms to Fund and Manage Product Development for Biotech & Small Pharma, in San Francisco. The New Paradigms conference is the only event addressing alternative sources to fund product development together with the impact of an effective Biomarker, Comparative Effectiveness and Outsourcing strategy to increase success rates.

August 9, 2010
GRS Offers New Commercialization Solutions in Collaboration with Dr. Peter Milner.
Press Release

June 13-17, 2010
DIA's 46th Annual Meeting, Washington, DC
Catherine Van Doren, Executive Director of Global Clinical Operations presented two sessions on effective global team management at the 2010 DIA Annual Meeting in Washington.

March 10, 2010
Andrea Pascual presented regulatory strategies in Latin America at CHI's Drug Development Latin America in Philadephia.

November 4, 2009
MMR Information Systems Engages Global Research Services as Advisor to Accelerate Time to Market for Anti-CD20 Monoclonal Antibodies
Press Release

July 2, 2009
Dr. Sandra Garrett selected by SmartCEO magazine as one of the top women business leaders in Washington, DC as part of the 2009 Brava! Women Business Achievement Awards.
Announcement

March 20, 2009
Dr. Sandra Garrett honored at Women In Bio Annual Dinner for the second year in a row because of significant contributions in forming and growing successful bioscience companies.
Announcement

January 22, 2009
GRS Increases EDC Capabilities through the Medidata ASPire to Win Program
Press Release

March 21, 2008
Dr. Sandra Garrett honored at Women In Bio 2008
Announcement

March 17, 2008
Global Research Services Announces Strategic Alliance Agreement with CardioDynamics
Press Release

March 11, 2008
Global Research Services Expands Clinical Trial Management Services in China with a Focus on Vaccine Development
Press Release

March 6, 2008
Global Research Services announces Phase I Core Data Service: Private Label Reserve
Press Release

February 11, 2008
U.S. launch of a clinical trial management on-line training initiative in collaboration with the University of Rochester Medical Center.
Press Release

March 23, 2007
Management Purchases the CRO Division of Medifacts International.
Press Release